0.3700
+0.0090
+(2.49%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,573.0000
-25,249.0000
-15,276.0000
-7,245.0000
-3,854.0000
Investing Cash Flow
775.0000
400.0000
-656.0000
--
--
Financing Cash Flow
14,031.0000
26,142.0000
5,354.0000
10,096.0000
10,444.0000
End Cash Position
140.0000
2,578.0000
1,285.0000
11,867.0000
9,022.0000
Interest Paid Supplemental Data
285.0000
404.0000
15.0000
12.0000
8.0000
Capital Expenditure
--
--
-660.0000
--
--
Issuance of Capital Stock
8,083.0000
23,053.0000
5,349.0000
9,054.0000
11,081.0000
Issuance of Debt
--
--
--
--
103.0000
Repayment of Debt
-1,000.0000
-1,650.0000
--
--
-860.0000
Repurchase of Capital Stock
--
-10.0000
--
--
--
Free Cash Flow
-15,573.0000
-25,249.0000
-15,936.0000
-7,245.0000
-3,854.0000
12/31/2020 - 1/3/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENTO Entero Therapeutics, Inc.
0.5899
-4.85%
IOBT IO Biotech, Inc.
0.8710
+1.79%
NEXI NexImmune, Inc.
0.1000
-1.96%
DRMA Dermata Therapeutics, Inc.
1.2000
-4.76%
ABVC ABVC BioPharma, Inc.
0.5540
+3.75%
TSOI Therapeutic Solutions International, Inc.
0.0002
-33.33%
MOLN Molecular Partners AG
4.9837
-5.97%
ERNA Eterna Therapeutics Inc.
0.3000
-7.21%
ENDV Endonovo Therapeutics, Inc.
0.0004
0.00%
TXTM ProText Mobility, Inc.
0.0011
0.00%